Literature DB >> 15742101

Acute hepatitis secondary to interferon beta-1a in multiple sclerosis.

V Christopher, N Scolding, R T Przemioslo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15742101     DOI： 10.1007/s00415-005-0767-2

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  6 in total

1.  Autoimmune hepatitis and interferon beta-1a for multiple sclerosis.

Authors:  Andrea Duchini
Journal:  Am J Gastroenterol       Date:  2002-03       Impact factor: 10.864

2.  Fulminant liver failure during interferon beta treatment of multiple sclerosis.

Authors:  E M Yoshida; S L Rasmussen; U P Steinbrecher; S R Erb; C H Scudamore; S W Chung; J J Oger; S A Hashimoto
Journal:  Neurology       Date:  2001-05-22       Impact factor: 9.910

Review 3.  Multiple sclerosis: side effects of interferon beta therapy and their management.

Authors:  E U Walther; R Hohlfeld
Journal:  Neurology       Date:  1999-11-10       Impact factor: 9.910

4.  PRISMS-4: Long-term efficacy of interferon-beta-1a in relapsing MS.

Authors: 
Journal:  Neurology       Date:  2001-06-26       Impact factor: 9.910

5.  Hepatic reactions during treatment of multiple sclerosis with interferon-beta-1a: incidence and clinical significance.

Authors:  Gordon S Francis; Yves Grumser; Enrica Alteri; Alain Micaleff; Fanny O'Brien; Jonathan Alsop; Margaretha Stam Moraga; Neil Kaplowitz
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

6.  Interferon beta-1a in primary progressive MS: an exploratory, randomized, controlled trial.

Authors:  S M Leary; D H Miller; V L Stevenson; P A Brex; D T Chard; A J Thompson
Journal:  Neurology       Date:  2003-01-14       Impact factor: 9.910
  6 in total
  4 in total

1.  Delayed Liver Function Impairment Secondary to Interferon β-1a Use in Multiple Sclerosis.

Authors:  Ming-Feng Liao; Su-Chen Yen; Lin Chun-Yen; Lyu Rong-Kuo
Journal:  Case Rep Neurol       Date:  2013-07-20

2.  Human VAP-B is involved in hepatitis C virus replication through interaction with NS5A and NS5B.

Authors:  Itsuki Hamamoto; Yorihiro Nishimura; Toru Okamoto; Hideki Aizaki; Minyi Liu; Yoshio Mori; Takayuki Abe; Tetsuro Suzuki; Michael M C Lai; Tatsuo Miyamura; Kohji Moriishi; Yoshiharu Matsuura
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

3.  GPS2 is required for the association of NS5A with VAP-A and hepatitis C virus replication.

Authors:  Guodong Xu; Xiu Xin; Congyi Zheng
Journal:  PLoS One       Date:  2013-11-04       Impact factor: 3.240

Review 4.  The Disease-Modifying Therapies of Relapsing-Remitting Multiple Sclerosis and Liver Injury: A Narrative Review.

Authors:  Marco Biolato; Assunta Bianco; Matteo Lucchini; Antonio Gasbarrini; Massimiliano Mirabella; Antonio Grieco
Journal:  CNS Drugs       Date:  2021-07-28       Impact factor: 5.749
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.